Residipok vs Nausea & Vomiting Tracker
Price, ratings, monetisation and update history for both apps, side by side β with what reviewers say about each.
Residipok
Read full descriptionHide full description
Residipok is a pocket reference for licensed healthcare professionals, trainees, and medical students of accredited health-professions programs. TWO MODULES (v0.4) β’ MIC Lookup Choose a bacterium and an antibiotic to see the EUCAST v16.0 (2026) Clinical Breakpoint thresholds β S, I, R bands by clinical context (systemic, meningitis, urinary, high-dose). Enter an MIC value to categorise it. Special states clearly labelled when no breakpoint is published or the organism is intrinsically resistant. Built especially for pan-resistance scenarios where every threshold matters. β’ ESC Guideline Reference Structured Class / Level of Evidence summaries of recent ESC cardiology guidelines, covering acute coronary syndromes, heart failure, atrial fibrillation, hypertension, endocarditis, cardiomyopathies, valvular disease, pulmonary hypertension and embolism, peripheral arterial disease, dyslipidaemia, prevention, pregnancy, syncope, supraventricular tachycardia, and more. Each recommendation card links back to the original guideline on escardio.org. IMPORTANT β REFERENCE ONLY β’ Residipok is NOT a medical device. β’ It does NOT diagnose, treat, cure, or prevent disease. β’ It is NOT a substitute for clinical judgement or for the original published guideline / breakpoint table. β’ Always verify against the current EUCAST table and the latest ESC document before clinical reporting. Requires confirmation of HCP / trainee status on first launch. Sign-in by email, Apple, or Google. Sources: EUCAST Clinical Breakpoint Tables v16.0 (2026); European Society of Cardiology Clinical Practice Guidelines (2018β2024).
Nausea & Vomiting Tracker
Read full descriptionHide full description
Nausea & Vomiting OS is a clinician-built logging app for chronic nausea and vomiting, including cyclic vomiting syndrome (CVS) and cannabinoid hyperemesis syndrome (CHS). Built by a practicing gastroenterologist, it captures the symptom patterns and clinical anchors that make a gastroenterology visit useful. What you log: β’ Nausea and vomiting episodes β frequency and duration β’ Cyclic pattern (CVS) and cannabinoid use (CHS) β’ Triggers and what brings relief (including hot-water bathing) β’ Hydration and weight What you get: β’ Todayβs note: written from your answers, with a plan you can read line by line and the reason behind each line β’ Episode burden tracked over time β’ For your next visit: what you recorded and the questions worth asking your gastroenterologist, on one page β’ Premium: a one-page visit report for your doctor, symptom trends and CSV export β’ A library on ACG-aligned nausea/vomiting evaluation, CVS guidance, and CHS recognition Privacy by design: β’ All data stays on your device. No accounts. No cloud sync. β’ No analytics. No ads. No data sale. About the developer: Nausea & Vomiting OS is built by a board-certified gastroenterologist. The app is decision-support β it does not diagnose, treat, or replace clinical care. Bring your data to your gastroenterologist. Premium: 14-day free trial, then a monthly or yearly subscription; the price for your country is shown before you subscribe. Premium can be shared with your family through Family Sharing. Subscriptions auto-renew; cancel anytime in App Store settings. Restore Purchases is available in the app and in Settings. Terms of Use (EULA): https://www.apple.com/legal/internet-services/itunes/dev/stdeula/
Screenshots
Verdict
The clearest difference is in-app purchases: Residipok at none against Nausea & Vomiting Tracker's 2. Residipok also leads on update cadence (every 2 weeks vs every 3 months). Nausea & Vomiting Tracker's advantage is ads (none vs shown). On price, device support and iOS requirement there is nothing between them.
Scored on Price Β· Rating Β· Positive reviews Β· Number of ratings Β· Update frequency Β· Ads Β· In-app purchases Β· Monetization Β· Best chart rank Β· Devices Β· Requires iOS
Both are free to download. Nausea & Vomiting Tracker sells 2 in-app purchases, starting at $4.99 per month. Residipok asks for nothing beyond the download.
Residipok ships an update every 2 weeks, Nausea & Vomiting Tracker every 3 months. Both last shipped on October 25, 2026.
| Parameter | Residipok | Nausea & Vomiting Tracker |
|---|---|---|
| Price | Free | Free |
| Update frequency | Every 2 weeks β better | Every 3 months |
| Ads | Yes | No β better |
| In-app purchases | No β better | Yes |
| Devices | iPhone, iPad, iPod | iPhone, iPad, iPod |
| Requires iOS | 15.1 | 15.0 β better |
| Further details β not scored | ||
| Size | 111 MB | 8 MB |
| Age rating | 17+ | 17+ |
| Developer | Maytham Al-taan | Muddusir Ayaz |
In-app purchases
Residipok
No in-app purchases
Nausea & Vomiting Tracker
- Nausea & Vomiting OS Monthly14 Days trial$4.991 Month
- Nausea & Vomiting OS Annual14 Days trial$29.991 Year






